Jiang Xi Sanxin Medtec Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100001ZJ1
CNY
9.62
0.14 (1.48%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Jiang Xi Sanxin Medtec Co., Ltd.

Why is Jiang Xi Sanxin Medtec Co., Ltd. ?

1
Positive results in Sep 25
  • DEBTORS TURNOVER RATIO(HY) Highest at 15.62 times
  • RAW MATERIAL COST(Y) Fallen by -12.1% (YoY)
  • CASH AND EQV(HY) Highest at CNY 953.74 MM
2
With ROE of 19.58%, it has a very attractive valuation with a 3.51 Price to Book Value
  • Over the past year, while the stock has generated a return of 21.38%, its profits have risen by 11.6% ; the PEG ratio of the company is 1.6
  • At the current price, the company has a high dividend yield of 3.3
3
Market Beating performance in long term as well as near term
  • Along with generating 21.38% returns in the last 1 year, the stock has outperformed China Shanghai Composite in the last 3 years, 1 year and 3 months
stock-recommendationReal-Time Research Report

Verdict Report

How much should you buy?

  1. Overall Portfolio exposure to Jiang Xi Sanxin Medtec Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Jiang Xi Sanxin Medtec Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Jiang Xi Sanxin Medtec Co., Ltd.
21.31%
1.06
35.65%
China Shanghai Composite
15.17%
1.02
14.86%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
11.45%
EBIT Growth (5y)
16.24%
EBIT to Interest (avg)
71.65
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.88
Tax Ratio
10.16%
Dividend Payout Ratio
67.93%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.45%
ROE (avg)
18.36%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
18
Industry P/E
Price to Book Value
3.51
EV to EBIT
17.69
EV to EBITDA
12.39
EV to Capital Employed
3.72
EV to Sales
2.96
PEG Ratio
1.55
Dividend Yield
3.28%
ROCE (Latest)
21.06%
ROE (Latest)
19.58%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
Mildly Bullish
OBV
Mildly Bearish
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

7What is working for the Company
DEBTORS TURNOVER RATIO(HY)

Highest at 15.62 times

RAW MATERIAL COST(Y)

Fallen by -12.1% (YoY

CASH AND EQV(HY)

Highest at CNY 953.74 MM

PRE-TAX PROFIT(Q)

Highest at CNY 89.11 MM

NET PROFIT(Q)

Highest at CNY 71.18 MM

EPS(Q)

Highest at CNY 0.13

-5What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at CNY 405.9 MM

OPERATING PROFIT(Q)

Lowest at CNY 76.32 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 18.76 %

Here's what is working for Jiang Xi Sanxin Medtec Co., Ltd.

Debtors Turnover Ratio
Highest at 15.62 times and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Pre-Tax Profit
Highest at CNY 89.11 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit
Highest at CNY 71.18 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS
Highest at CNY 0.13
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Cash and Eqv
Highest at CNY 953.74 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost
Fallen by -12.1% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Jiang Xi Sanxin Medtec Co., Ltd.

Operating Cash Flow
Lowest at CNY 405.9 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Operating Profit
Lowest at CNY 76.32 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 18.76 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales